Closed tender

Pharmaceutical products

Details

Buyer
Wojewódzki Szpital Zespolony im. L. Perzyny w Kaliszu
Value
PLN 11,360,203
Topic
Pharmaceutical products
Published
27 January 2018
Submission
8 March 2018

Tender description

Sukcesywne dostawy produktów farmaceutycznych. Przedmiot zamówienia składa się z 18 niepodzielnych zadań, których szczegółowy opis znajduje się w Specyfikacji Istotnych Warunków Zamówienia. Leki stosowane w terapii bezinterferonowej WZW typu C: Dazabuwir - 200 op, Ombitaswir, Parytaprewir, Rytonawir - 200op, Rybawiryna - 50 op. Ledipasvir, Sofosbuvir - 100 op. Sofosbuvir - 24 op. Elbasvir, Grazoprevir - 12op. Abiraterone - 5op. Aflibercept - 10op. Axitinib - 5op. Doxorubicin hydrochloride - 10op. Everolimus - 3op. Paclitaxel - 50op. Pazopanib - 6op. Sorafenib - 2op. Sunitinib - 4op. Temsirolimus - 5op. Trastuzumab - 28op. Bleomycin sulphate - 50op. Carbolatinum - 320op. Enzalutamide - 5op.

Timeline

  1. Completed: Tender published27 January 2018
    Current notice
  2. Completed: Submission date8 March 2018

About the buyer

Wojewódzki Szpital Zespolony im. L. Perzyny w Kaliszu is a public sector buyer in Poland publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to Pharmaceutical products.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.